Modular clinical pharmacology study to evaluate the drug-drug interaction potential and relative bioavailability of saruparib

Trial Identifier:	D9723C00002
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	March 2025
Primary Completion Date:	July 2026
Study Completion Date:	November 2026
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
BG	Sofia, BG, 1618
MD	Chisinau, MD, MD-2025
RO	Bucuresti, RO, 022338
RO	Cluj Napoca, RO, 400015

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.